Literature DB >> 15865876

Karyotype and molecular cytogenetic studies in polycythemia vera.

Joris Loup Andrieux1, Jean Loup Demory.   

Abstract

A minority of patients with newly diagnosed polycythemia vera (PV) have an abnormal karyotype in their myeloid cells but no invariant chromosomal aberration has been found. The most frequent visible alteration is a 20q deletion, also characterized in other myeloproliferative diseases (MPD) and myeloid malignancies; among other chromosomal changes, trisomy 9 appears more common in PV than in other MPDs. When a myelofibrosis complicates the course of the disease, cytogenetic anomalies become quite common with a striking frequency of partial duplication 1q; an evolution towards myelodysplasia or acute leukemia is almost always associated with nonspecific chromosomal aberrations. Modern cytogenetic methods have disclosed cryptic anomalies and pointed out the high frequency of 9p alterations affecting a restricted region, thus stimulating an active search for candidate genes or specific mutations.

Entities:  

Mesh:

Year:  2005        PMID: 15865876

Source DB:  PubMed          Journal:  Curr Hematol Rep        ISSN: 1540-3408


  6 in total

1.  Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53.

Authors:  Bridget K Marcellino; Ronald Hoffman; Joseph Tripodi; Min Lu; Heidi Kosiorek; John Mascarenhas; Raajit K Rampal; Amylou Dueck; Vesna Najfeld
Journal:  Blood Adv       Date:  2018-12-26

Review 2.  Leukemia secondary to myeloproliferative neoplasms.

Authors:  Andrew J Dunbar; Raajit K Rampal; Ross Levine
Journal:  Blood       Date:  2020-07-02       Impact factor: 22.113

3.  Significance of cytogenetic abnormalities in patients with polycythemia vera.

Authors:  Matjaz Sever; Alfonso Quintás-Cardama; Sherry Pierce; Lingsha Zhou; Hagop Kantarjian; Srdan Verstovsek
Journal:  Leuk Lymphoma       Date:  2013-04-17

4.  A rare der(Y)t(Y;1)(q12;q12) in a patient with post-polycythemic myelofibrosis: a case report.

Authors:  Masahiro Manabe; Osami Takeda; Junya Okita; Teruhito Takakuwa; Naonori Harada; Hirofumi Nakano; Shuichiro Okamoto; Yasutaka Aoyama; Takeo Kumura; Tadanobu Ohta; Yoshio Furukawa; Atsuko Mugitani
Journal:  Am J Blood Res       Date:  2013-05-05

5.  Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera.

Authors:  Guilin Tang; Juliana E Hidalgo Lopez; Sa A Wang; Shimin Hu; Junsheng Ma; Sherry Pierce; Wenli Zuo; Adrian Alejandro Carballo-Zarate; C Cameron Yin; Zhenya Tang; Shaoying Li; L Jeffrey Medeiros; Srdan Verstovsek; Carlos E Bueso-Ramos
Journal:  Haematologica       Date:  2017-05-04       Impact factor: 9.941

6.  A Novel Acquired t(2;4)(q36.1;q24) with a Concurrent Submicroscopic del(4)(q23q24) in An Adult with Polycythemia Vera.

Authors:  Eigil Kjeldsen
Journal:  Cancers (Basel)       Date:  2018-06-25       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.